Vaxart
(NASDAQ:VXRT)
$1.3091
0.0191[1.48%]
At close: Mar 28
$1.3091
0[0.00%]
After Hours: 6:50PM EDT
Consensus Rating1
Overweight
Highest Price Target1
$18.00
Lowest Price Target1
$2.00
Consensus Price Target1
$9.25

Vaxart Stock (NASDAQ:VXRT), Analyst Ratings, Price Targets, Predictions

Vaxart Inc has a consensus price target of $9.25, established from looking at the 10 latest analyst ratings. The last 3 analyst ratings were released from B. Riley Securities, Cantor Fitzgerald, and Cantor Fitzgerald on January 31, 2024, September 7, 2023, and August 7, 2023. With an average price target of $3.33 between B. Riley Securities, Cantor Fitzgerald, and Cantor Fitzgerald, there's an implied 154.63% upside for Vaxart Inc from these 3 analyst ratings.

Analyst Rating Summary1

Analyst Ratings
Jan
1
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

B. Riley Securities
Cantor Fitzgerald
Jefferies
Piper Sandler

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Vaxart

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
01/31/2024VXRTBuy Now
Vaxart
$1.3152.78%B. Riley Securities
Mayank Mamtani
→ $2UpgradeNeutral → BuyGet Alert
09/07/2023VXRTBuy Now
Vaxart
$1.31205.55%Cantor Fitzgerald
Charles Duncan
→ $4ReiteratesOverweight → OverweightGet Alert
08/07/2023VXRTBuy Now
Vaxart
$1.31205.55%Cantor Fitzgerald
Charles Duncan
$6 → $4MaintainsOverweightGet Alert
12/19/2022VXRTBuy Now
Vaxart
$1.3114.58%B. Riley Securities
Mayank Mamtani
$6 → $1.5MaintainsNeutralGet Alert
09/02/2022VXRTBuy Now
Vaxart
$1.31511.11%Cantor Fitzgerald
Charles Duncan
$11 → $8MaintainsOverweightGet Alert
05/19/2022VXRTBuy Now
Vaxart
$1.31358.33%B. Riley Securities
Mayank Mamtani
$7 → $6MaintainsNeutralGet Alert
11/02/2021VXRTBuy Now
Vaxart
$1.311045.83%Cantor Fitzgerald
Charles Duncan
Initiates → OverweightGet Alert
06/30/2021VXRTBuy Now
Vaxart
$1.31587.5%B. Riley Securities
Mayank Mamtani
DowngradeBuy → NeutralGet Alert
06/24/2021VXRTBuy Now
Vaxart
$1.31893.05%Jefferies
Kelechi Chikere
Initiates → BuyGet Alert
06/11/2021VXRTBuy Now
Vaxart
$1.311274.99%Piper Sandler
Yasmeen Rahimi
Initiates → OverweightGet Alert

FAQ

Q

What is the target price for Vaxart (VXRT)?

A

The latest price target for Vaxart (NASDAQ: VXRT) was reported by B. Riley Securities on January 31, 2024. The analyst firm set a price target for $2.00 expecting VXRT to rise to within 12 months (a possible 52.78% upside). 3 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Vaxart (VXRT)?

A

The latest analyst rating for Vaxart (NASDAQ: VXRT) was provided by B. Riley Securities, and Vaxart upgraded their buy rating.

Q

When was the last upgrade for Vaxart (VXRT)?

A

The last upgrade for Vaxart Inc happened on January 31, 2024 when B. Riley Securities raised their price target to $2. B. Riley Securities previously had a neutral for Vaxart Inc.

Q

When was the last downgrade for Vaxart (VXRT)?

A

The last downgrade for Vaxart Inc happened on June 30, 2021 when B. Riley Securities changed their price target from $13 to $9 for Vaxart Inc.

Q

When is the next analyst rating going to be posted or updated for Vaxart (VXRT)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Vaxart, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Vaxart was filed on January 31, 2024 so you should expect the next rating to be made available sometime around January 31, 2025.

Q

Is the Analyst Rating Vaxart (VXRT) correct?

A

While ratings are subjective and will change, the latest Vaxart (VXRT) rating was a upgraded with a price target of $0.00 to $2.00. The current price Vaxart (VXRT) is trading at is $1.31, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch